{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:45:24Z","timestamp":1792154724964,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1124\/jpet.113.206086","type":"journal-article","created":{"date-parts":[[2013,7,13]],"date-time":"2013-07-13T00:17:43Z","timestamp":1373674663000},"page":"545-554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Physical Presence of Nor-Binaltorphimine in Mouse Brain over 21 Days after a Single Administration Corresponds to Its Long-Lasting Antagonistic Effect on \u03ba-Opioid Receptors"],"prefix":"10.1016","volume":"346","author":[{"given":"Kshitij A.","family":"Patkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Ganno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harminder D.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolette C.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khampaseuth","family":"Rasakham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Toll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay P.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.113.206086_bib1","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1126\/science.1251210","article-title":"Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist","volume":"191","author":"Akil","year":"1976","journal-title":"Science"},{"key":"10.1124\/jpet.113.206086_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1208\/s12248-009-9105-4","article-title":"Peptide \u03ba opioid receptor ligands: potential for drug development","volume":"11","author":"Aldrich","year":"2009","journal-title":"AAPS J"},{"key":"10.1124\/jpet.113.206086_bib3","series-title":"Burger's Medicinal Chemistry and Drug Discovery","article-title":"Narcotic analgesics","author":"Aldrich","year":"2002"},{"key":"10.1124\/jpet.113.206086_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00213-005-0167-4","article-title":"Differential effects of the novel \u03ba opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats","volume":"183","author":"Beardsley","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.206086_bib43","first-page":"248","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"47","author":"Bradford","year":"1976","journal-title":"J Org Chem"},{"key":"10.1124\/jpet.113.206086_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02245071","article-title":"Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on \u03ba-opioid agonists in the mouse writhing assay","volume":"115","author":"Broadbear","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.206086_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-010-1806-y","article-title":"Kinase cascades and ligand-directed signaling at the \u03ba opioid receptor","volume":"210","author":"Bruchas","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.206086_bib7","doi-asserted-by":"crossref","first-page":"29803","DOI":"10.1074\/jbc.M705540200","article-title":"Long-acting \u03ba opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase","volume":"282","author":"Bruchas","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.113.206086_bib8","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0022-3565(25)39577-7","article-title":"\u03ba opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys","volume":"267","author":"Butelman","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.206086_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2007.05.007","article-title":"Reinstatement of cocaine place-conditioning prevented by the peptide \u03ba-opioid receptor antagonist arodyn","volume":"569","author":"Carey","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.206086_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2005.09.013","article-title":"Effects of JDTic, a selective \u03ba-opioid receptor antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion model","volume":"524","author":"Carroll","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.206086_bib11","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1021\/jm00052a008","article-title":"\u03ba Opioid receptor selective affinity labels: electrophilic benzeneacetamides as \u03ba-selective opioid antagonists","volume":"37","author":"Chang","year":"1994","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.113.206086_bib12","doi-asserted-by":"crossref","first-page":"21422","DOI":"10.1074\/jbc.271.35.21422","article-title":"Determination of the amino acid residue involved in [3H]\u03b2-funaltrexamine covalent binding in the cloned rat \u03bc-opioid receptor","volume":"271","author":"Chen","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.113.206086_bib13","first-page":"30","article-title":"Nor-binaltorphimine: a potent and selective \u03ba-opioid receptor antagonist with long-lasting activity in vivo","volume":"316","author":"Endoh","year":"1992","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1124\/jpet.113.206086_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1476-5381.1957.tb01354.x","article-title":"Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse","volume":"12","author":"Haley","year":"1957","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1124\/jpet.113.206086_bib15","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0022-3565(25)11434-1","article-title":"Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test","volume":"260","author":"Horan","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.206086_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2004.12.035","article-title":"BU74, a complex oripavine derivative with potent \u03ba opioid receptor agonism and delayed opioid antagonism","volume":"509","author":"Husbands","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.206086_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0014-2999(92)90055-9","article-title":"Long term \u03ba-opioid receptor blockade following nor-binaltorphimine","volume":"215","author":"Jones","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.206086_bib18","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1021\/jm9805182","article-title":"Mutational evidence for a common \u03ba antagonist binding pocket in the wild-type \u03ba and mutant \u03bc[K303E] opioid receptors","volume":"41","author":"Jones","year":"1998","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.113.206086_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1124\/jpet.104.065078","article-title":"\u03ba-opioid receptor signals through Src and focal adhesion kinase to stimulate c-Jun N-terminal kinases in transfected COS-7 cells and human monocytic THP-1 cells","volume":"310","author":"Kam","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.206086_bib20","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.107.127415","article-title":"Anxiolytic-like effects of \u03ba-opioid receptor antagonists in models of unlearned and learned fear in rats","volume":"323","author":"Knoll","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.206086_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of \u03ba-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.206086_bib22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/jaoac\/94.1.136","article-title":"Development and validation of an HPLC\/MS\/MS method for the determination of sufentanil and morphine in human plasma","volume":"94","author":"Manfio","year":"2011","journal-title":"J AOAC Int"},{"key":"10.1124\/jpet.113.206086_bib23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0022-3565(24)38137-6","article-title":"Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of \u03bc-selective agonist and antagonist activity","volume":"289","author":"McLaughlin","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.206086_bib24","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1074\/jbc.M305796200","article-title":"Prolonged \u03ba opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance","volume":"279","author":"McLaughlin","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.113.206086_bib25","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1073\/pnas.1000751107","article-title":"Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling","volume":"107","author":"Melief","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.113.206086_bib26","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/mol.111.074195","article-title":"Duration of action of a broad range of selective \u03ba-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation","volume":"80","author":"Melief","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.113.206086_bib27","doi-asserted-by":"crossref","first-page":"E704","DOI":"10.1208\/aapsj070371","article-title":"\u03ba opioid antagonists: past successes and future prospects","volume":"7","author":"Metcalf","year":"2005","journal-title":"AAPS J"},{"key":"10.1124\/jpet.113.206086_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2210-12-5","article-title":"Long-acting \u03ba opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity","volume":"12","author":"Munro","year":"2012","journal-title":"BMC Pharmacol"},{"key":"10.1124\/jpet.113.206086_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2004.07.097","article-title":"Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting \u03bc-opioid receptor agonist","volume":"499","author":"Neilan","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.206086_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2011.04.017","article-title":"Identification of short-acting \u03ba-opioid receptor antagonists with anxiolytic-like activity","volume":"661","author":"Peters","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.206086_bib31","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0024-3205(87)90585-6","article-title":"Binaltorphimine and nor-binaltorphimine, potent and selective \u03ba-opioid receptor antagonists","volume":"40","author":"Portoghese","year":"1987","journal-title":"Life Sci"},{"key":"10.1124\/jpet.113.206086_bib32","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.biopsych.2011.05.021","article-title":"Repeated exposure to the \u03ba-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity","volume":"70","author":"Potter","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.113.206086_bib33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0740-5472(99)00074-4","article-title":"An open-label study of a functional opioid \u03ba antagonist in the treatment of opioid dependence","volume":"18","author":"Rothman","year":"2000","journal-title":"J Subst Abuse Treat"},{"key":"10.1124\/jpet.113.206086_bib34","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/0028-3908(89)90009-9","article-title":"A study of the interaction of the alkylating agent, NIH10236, with opioid receptors in vitro and in vivo","volume":"28","author":"Rothman","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.113.206086_bib35","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1039\/c3np70003h","article-title":"Glucuronides from metabolites to medicines: a survey of the in vivo generation, chemical synthesis and properties of glucuronides","volume":"30","author":"Stachulski","year":"2013","journal-title":"Nat Prod Rep"},{"key":"10.1124\/jpet.113.206086_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-3565(25)21011-4","article-title":"Nor-binaltorphimine, a highly selective \u03ba-opioid antagonist in analgesic and receptor binding assays","volume":"246","author":"Takemori","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.206086_bib37","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1021\/jm015521r","article-title":"Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective \u03ba-opioid receptor antagonist activity","volume":"44","author":"Thomas","year":"2001","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.113.206086_bib38","first-page":"440","article-title":"Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications","volume":"178","author":"Toll","year":"1998","journal-title":"NIDA Res Monogr"},{"key":"10.1124\/jpet.113.206086_bib39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-2999(82)90083-8","article-title":"Pharmacological profiles of \u03b2-funaltrexamine (\u03b2-FNA) and \u03b2-chlornaltrexamine (\u03b2-CNA) on the mouse vas deferens preparation","volume":"80","author":"Ward","year":"1982","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.206086_bib40","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/npp.2008.142","article-title":"Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone","volume":"34","author":"Wittmann","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.113.206086_bib41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0028-3908(91)90006-W","article-title":"(+)-cis-3-methylfentanyl and its analogs bind pseudoirreversibly to the \u03bc opioid binding site: evidence for pseudoallosteric modulation","volume":"30","author":"Xu","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.113.206086_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2007.05.045","article-title":"Central \u03ba-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies","volume":"570","author":"Zhang","year":"2007","journal-title":"Eur J Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524287498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524287498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.113.206086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:16:37Z","timestamp":1739996197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524287498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0022356524287498"],"URL":"https:\/\/doi.org\/10.1124\/jpet.113.206086","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physical Presence of Nor-Binaltorphimine in Mouse Brain over 21 Days after a Single Administration Corresponds to Its Long-Lasting Antagonistic Effect on \u03ba-Opioid Receptors","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.113.206086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}